Do I manufacture my drug in China or should I import? Which registration category for my product is likely to win approval the fastest? Do I integrate China into an existing global trial, or do I make China trials independent? Do I outsource the sales and marketing to a distributor, or do I develop the drug with a pharmaceutical company that has sales and marketing capability?
These are major strategic questions that could determine the success of your product, as well as its profitability. They require both a wide range of knowledge across the industry and a depth of expertise in specific areas. Our consultants come from the few teams in China who have had experience bringing a class I innovative drug to market from the research lab, through clinical trials to regulatory approval. We have experience advising multinational companies in their development plan for specific products. In addition, our network of advisors possesses in-depth expertise in relevant areas and provides access to additional resources that might be necessary.
We examine your product in its relevant regulatory, clinical and sales and marketing environment in a comprehensive study. We lay out the available options for your product, evaluate the pros and cons of each, and work with you to make the right decision. Once a development strategy is in place, we get official and informal confirmation from relevant sources to confirm its feasibility and ensure the highest possible success rate.
To find out more about our work in this area, please contact inquiries@modularrandd.com.